Recent Updates
Recently added Catalysts
STAA Positive Sentiment

STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer

Key Takeaway: STAAR Surgical has appointed Ben Park, Ph.D., as Chief Technology Officer. This strategic move aims to transition the company from a single-product focus to a multi-product platform. Dr. Park will be part of the Executive Committee and report directly to the CEO, Warren Foust.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Ben Park as CTO indicates strategic growth.
  • Dr. Park's experience will enhance STAAR's technology development.
  • Focus on evolving into a multi-product platform is promising.

Full Press Release Details

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of Ben Park, Ph.D., as Chief Technology Officer. Dr. Park will join STAAR's Executive Committee and report to Warren Foust, President and Chief Executive Officer. "Evolving STAAR from a single-product focus into a multi-product platform is cent

Frequently Asked Questions

Who is the new Chief Technology Officer of STAAR Surgical?

Ben Park, Ph.D., has been appointed as the new Chief Technology Officer.

What is the goal of STAAR Surgical's new CTO?

The goal is to evolve STAAR from a single-product focus to a multi-product platform.

Who does Ben Park report to at STAAR Surgical?

Ben Park will report to Warren Foust, the President and CEO.

What is STAAR Surgical known for?

STAAR Surgical is a leader in phakic IOLs, particularly the EVO family of lenses.

Last updated: Sep 2, 2026